Navigation Links
Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009
Date:5/6/2009

he product launched. Through the first three months of 2009, Par remained the exclusive supplier of generic Imitrex(R) 4mg and 6mg starter kits and 4mg prefilled cartridges and had one competitor in the 6mg prefilled cartridges.

  • Meclizine: Net sales for the three months ended March 28, 2009 were $9.8 million compared to $10.8 million in the fourth quarter of 2008. Par was the exclusive supplier of meclizine in the first quarter of 2009.

  • Dronabinol: Net sales for the first quarter 2009 were $7.0 million. This compares to $6.4 million in the fourth quarter 2008. Through the first quarter of 2009, Par was one of two distributors of generic Marinol(R).

  • Other generic products: For the first quarter 2009, revenues from all other generic products were $43.0 million, a decrease of approximately $11 million from the fourth quarter 2008. The decline reflects a decrease in the number of products sold as a result of Par's discontinuation of less profitable products from its portfolio, a process that was refined in the fourth quarter of 2008.

  • Megace(R) ES: Net sales were $13.5 million for the three months ended March 28, 2009 compared with $19.7 million in the fourth quarter. The decrease in net sales was due primarily to the trade accelerating its Megace ES purchases in the fourth quarter before the holiday to the detriment of the first quarter. However, prescription levels were up slightly compared to the fourth quarter of 2008.

Total net revenues for the three months ended March 28, 2009, were $204.0 million, up $49.1 million, or nearly 32%, from the year ago period, principally driven by gains in metoprolol succinate, sumatriptan i
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Yesterday, Senator Holly Mitchell (D-Los ... Olsen (R-Modesto) were honored by the California Healthcare ... biomedical science, medical device and pharmaceutical innovation in ... “2014 Life Sciences Champion” award from CHI President ...
(Date:1/22/2015)... IsoComforter, Inc. has introduced the most innovative and easy ... treat specific body parts and muscle groups. , IsoComforter, ... use patented cold therapy machine with the innovative IsoTube design ... injuries. IsoComforter has become the industry leader in cold ...
(Date:1/22/2015)... WASHINGTON, DC (PRWEB) January 22, 2015 ... conditions in vulnerable communities and cause financial distress to ... report by analysts at Howard University’s Center on Race ... of dollars in economic activity, payday loans at the ...
(Date:1/22/2015)... As interest in the value of spiritual ... worldwide, Rev. Eric J. Hall , president and CEO ... will be the keynote speaker on January 27 at an ... system. , The conference, “Hope and Resilience: Innovative and Interdisciplinary ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Compare-autoinsurance.org has released a ... insured by an auto insurance policy . , Some ... policy. Clients should check the newly released blog post to see ... cars and dangerously damaged vehicles are some of the cars that ...
Breaking Medicine News(10 mins):Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2
... premier medical and surgical equipment supplier, expands its extensive ... ... (Vocus) April 13, 2009 -- DRE, Inc.—recently named a Company ... new and professionally refurbished healthcare equipment to include the DRE Tempo ...
... researchers has for the first time used tiny molecules called microRNAs to help ... pluripotent, meaning that, like embryonic stem cells , they have the capacity ... ... A team of UCSF researchers has for the first time used ...
... plan in the continental U.S. to offer consumers new ... Imagine being able to talk immediately with a physician who ... questions, make diagnoses and prescribe medications - doing all of ... or a phone. Consumers in Minnesota soon will be ...
... chunk of tissue smaller than the period at the end ... necessary to diagnose cancers and assess their response to treatment, ... In a study to be published April 12 in the ... a specialized machine capable of analyzing whether individual cancer-associated proteins ...
... COVER: "The Mystery of Epilepsy " (p. 38). Newsweek ... a cancerlike sensibility around epilepsy. We cannot usually see our ... for a cure for different cancers with the utmost cultural and ... The toll of epilepsy has been overlooked -- and the research ...
... computer accessories provide infrared heat therapy using infrared heaters in ... pain diagnosis results in cold computer hands and numb cold ... provides warmth and relief. , ... ...
Cached Medicine News:Health News:DRE Medical Equipment Adds Compact Fetal Monitors to Its Product Lineup 2Health News:DRE Medical Equipment Adds Compact Fetal Monitors to Its Product Lineup 3Health News:UCSF Team Closer to Creating Safe Embryonic-Like Stem Cells 2Health News:UCSF Team Closer to Creating Safe Embryonic-Like Stem Cells 3Health News:UCSF Team Closer to Creating Safe Embryonic-Like Stem Cells 4Health News:Blue Cross and Blue Shield of Minnesota and American Well(TM) Join to Bring Online Care to Minnesota 2Health News:Blue Cross and Blue Shield of Minnesota and American Well(TM) Join to Bring Online Care to Minnesota 3Health News:Blue Cross and Blue Shield of Minnesota and American Well(TM) Join to Bring Online Care to Minnesota 4Health News:New alternative to biopsy detects subtle changes in cancer cells, Stanford study shows 2Health News:New alternative to biopsy detects subtle changes in cancer cells, Stanford study shows 3Health News:NEWSWEEK: Media Lead Sheet/April 20, 2009 Issue 2Health News:NEWSWEEK: Media Lead Sheet/April 20, 2009 Issue 3Health News:NEWSWEEK: Media Lead Sheet/April 20, 2009 Issue 4Health News:NEWSWEEK: Media Lead Sheet/April 20, 2009 Issue 5Health News:Arthritis Hand Pain Relief: Infrared Heat Therapy Ergonomic Computer Workstation 2
(Date:1/23/2015)... plc (NYSE: MNK ) announced today that ... program. The open-ended authorization permits the company to repurchase ... "Funding additional initiatives and seeking attractive ... to pursue a range of focused growth strategies," said ...
(Date:1/22/2015)... a privately held medical device company, announced today that ... ITOCHU Corporation (Tokyo Stock Exchange TYO: 8001) to sell ... cancer in Japan . ViewRay,s technology, ... only MRI-guided radiation therapy system that images and treats ...
(Date:1/22/2015)... , Jan. 22, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ... focus on Omega-3 therapies for cardiovascular disease and overall health ... Company,s accomplishments in 2014 and its outlook for 2015 from ... Fellow Shareholders, We would like to take this ...
Breaking Medicine Technology:Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: